Contra Avi Genomic Medicine Inc.
13F holders, Q1 2024 (March 31)1holders
$0.15avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Contra Avi Genomic Medicine Inc. in their 13F filings. The largest holder was Verity Asset Management, Inc. ($4K).
- Company
- Contra Avi Genomic Medicine Inc.
- CUSIP
- 008CVR011
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Verity Asset Management, Inc. | 0.00% | No change | 30,500 | $4K |
"% of holder's portfolio" is CONTRA AVI GENOMIC MEDICINE INC's weight in each manager's 13F, not the share of Contra Avi Genomic Medicine Inc. the manager owns.